Related Experiment Video
Updated: Feb 24, 2026

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
A cost-benefit analysis of a National Hypertension Treatment Program in Bangladesh
Rachel Nugent1, Elizabeth Brower2, Alejandro Cravioto3
1RTI International, United States.
Insights
Investing in hypertension management in Bangladesh offers significant economic benefits. Proactive treatment of high blood pressure can yield substantial returns on investment and prevent premature deaths.
Area of Science:
- Public Health Economics
- Cardiovascular Disease Prevention
Background:
- Hypertension is a leading global risk factor for stroke and myocardial infarction.
- High rates of hypertension exist in Bangladesh, affecting one in three women and one in five men.
- Bangladesh faces an epidemiological transition, presenting an opportunity to manage hypertension.
Purpose of the Study:
- To model the return on investment (ROI) of increasing anti-hypertensive drug coverage in Bangladesh.
- To analyze the economic impact of hypertension management from a societal perspective.
- To stratify ROI projections by gender and income quintile.
Main Methods:
- Economic cost-benefit analysis was employed.
- A societal perspective was adopted for the analysis.
- The study modeled the ROI of providing blood-pressure lowering drugs to 60% of hypertensive adults by 2021 and 2030.
Main Results:
- Proactive hypertension management could yield an annual ROI of 12.7:1 by 2021 and 8.6:1 by 2030.
- The ROI is higher for providing medication to women compared to men.
- Economic benefits are projected across different time horizons and demographic groups.
Conclusions:
- Bangladesh has a critical window to address hypertension and realize significant economic gains.
- Intervention can prevent thousands of premature deaths.
- Substantial net economic benefits are achievable within six years of proactive management.
Introduction:
Hypertension is one of the most common, yet manageable, risks for life-threatening events like stroke and myocardial infarction in the world. Bangladesh adults experience high rates of hypertension, with one in three women and one in five men meeting the condition's clinical definition. In the midst of an epidemiological transition, Bangladesh has the opportunity to slow the growth of hypertension prevalence through increased coverage of anti-hypertensive drugs for high-risk patients.
Methods:
Using economic cost-benefit analysis and a societal perspective, we model the return on investment of providing blood-pressure lowering drugs to 60% of hypertensive adults by 2021 and 2030. We stratify the projections on both gender and income quintile.
Results:
If the government of Bangladesh is proactive about hypertension management now, they could see a 12.7: 1 annual return on investment by 2021 and an 8.6: 1 annual return on investment by 2030. The return on investment is higher for providing medication for women than for men in both time horizons.
Conclusion:
Bangladesh has a unique opportunity to address hypertension now in order to prevent thousands of premature deaths and to accrue substantial net economic benefits within 6years.
Related Concept Videos
Errors occurring during blood pressure monitoring
Several factors...
Hypertension V: Nursing Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction

